Dataset | Â | Gene Selection Method | |||||||
---|---|---|---|---|---|---|---|---|---|
MaPSOGS | Geometric PSO | PSO | RMA | RPSW | EPSO | Hybrid BPSO-BBHA | PSOC4.5 | ||
AMLGSE2191 | Acc (%) | 95.36 (1) | 87.08 (7) | 81.16 (8) | 95.11 (2) | 90.79 (6) | 91.22 (4) | 91.05 (5) | 93.39 (3) |
 | Std | 2.33 | 7.15 | 5.78 | 1.23 | 8.04 | 3.99 | 4.57 | 3.50 |
Colon | Acc (%) | 96.18 (1) | 86.76 (7) | 84.88 (8) | 94.10 (2) | 90.55 (4) | 88.21 (6) | 90.36 (5) | 91.45 (3) |
 | Std | 0.24 | 4.77 | 6.42 | 1.70 | 5.49 | 4.87 | 5.12 | 3.10 |
DLBCL | Acc (%) | 93.89 (1) | 86.96 (7) | 82.83 (8) | 91.49 (2) | 91.18 (3) | 89.64 (5) | 88.07 (6) | 90.39 (4) |
 | Std | 0.59 | 5.11 | 4.96 | 1.94 | 3.07 | 2.79 | 2.94 | 2.28 |
Leukaemia | Acc (%) | 93.81 (1) | 84.14 (7) | 82.66 (8) | 91.95 (3) | 88.71 (5) | 87.19 (6) | 89.06 (4) | 91.88 (2) |
 | Std | 4.17 | 4.17 | 3.69 | 2.91 | 4.17 | 3.60 | 4.02 | 3.62 |
Prostate | Acc (%) | 94.25 (1) | 80.83 (8) | 82.69 (7) | 93.77 (2) | 90.26 (3) | 85.55 (6) | 86.37 (5) | 90.04 (4) |
 | Std | 2.41 | 5.53 | 7.01 | 4.84 | 4.26 | 5.03 | 2.50 | 3.09 |
MLL | Acc (%) | 93.74 (1) | 81.49 (7) | 80.90 (8) | 91.55 (2) | 83.72 (6) | 88.78 (4) | 86.44 (5) | 90.61 (3) |
 | Std | 1.01 | 3.13 | 4.25 | 3.05 | 3.83 | 4.45 | 3.96 | 3.77 |
SRBCT | Acc (%) | 94.90 (1) | 81.96 (7) | 81.13 (8) | 92.53 (2) | 90.11 (4) | 90.01 (5) | 88.83 (6) | 91.39 (3) |
 | Std | 2.85 | 4.18 | 3.18 | 3.21 | 5.73 | 3.97 | 2.98 | 2.19 |
Average | Acc (%) | 94.59 (1) | 84.18 (7.14) | 82.32 (7.85) | 92.93 (2.14) | 89.33 (4.42) | 88.66 (5.14) | 88.60 (5.14) | 91.31 (3.14) |
 | Std | 1.94 | 4.86 | 5.04 | 2.70 | 4.94 | 4.1 | 3.73 | 3.08 |